SCHEMBL7714952

SCHEMBL7714952

COC(=O)C(F)c1ccc(N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.46
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAOA P21397 1/20 0.39
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
DHFR P00374 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALOX5 P09917 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27441057 0.82 ESR1 (0.54) KMT2AESR1ESR2CA12CA1
SCHEMBL11861772 0.82 KEAP1 (0.45) KMT2ALMNAALDH1A1TDP1ALOX5
SCHEMBL11260308 0.81 LMNA (0.53) KMT2ALMNACYP1A2CYP3A4MAOA
SCHEMBL28902582 0.81 L3MBTL1 (0.49) SLC6A3KMT2ACNR2L3MBTL1
SCHEMBL20943223 0.81 CYP1A2 (0.48) KMT2ACYP1A2ALDH1A1TSHRSMN1; SMN2
SCHEMBL4518771 0.81 SLC6A3 (0.46) SLC6A3KMT2AALDH1A1F2PRSS1
SCHEMBL20943230 0.80 LOXL2 (0.51) KMT2AKDM4EPRSS1SMN1; SMN2ESR1
SCHEMBL27450233 0.80 APP (0.38) SLC6A3KMT2ALMNACYP1A2CYP3A4
SCHEMBL3526852 0.80 ALDH1A1 (0.56) SLC6A3KMT2ALMNACYP1A2CYP3A4
SCHEMBL2078143 0.80 KMT2A (0.64) SLC6A3KMT2ALMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865421-B1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LTD (GB) 2002-03-27 EP disclosed
US-6048872-A DIETETICS; ANTIDIABETIC AGENTS; CARDIOVASCULAR DISORDERS; GASTROINTESTINAL DISORDERS GLAXO WELLCOME INC. (US) 2000-04-11 US disclosed
EP-0865421-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1998-09-23 EP disclosed
WO-1997021665-A1 ARYLETHANOLAMINE DERIVATIVES AND THEIR USE AS AGONISTS OF ATYPICAL BETA-ADRENOCEPTORS GLAXO GROUP LIMITED (GB) 1997-06-19 WO disclosed